Loading...

ENDRA Life Sciences Inc.

NDRA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$4.97
$-0.03(-0.60%)
U.S. Market opens in 23h 4m

ENDRA Life Sciences Inc. (NDRA) Stock Overview

Explore ENDRA Life Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.7M
P/E Ratio-0.54
EPS (TTM)$-8.93
ROE-4.97%
Fundamental Analysis

AI Price Forecasts

1 Month$0.70
3 Months$0.00
1 Year Target$0.00

NDRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ENDRA Life Sciences Inc. (NDRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.54 and a market capitalization of 3.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.60%
5-Day Change
-3.31%
1-Month Change
43.64%
3-Month Change
11.69%
6-Month Change
-0.60%
Year-to-Date (YTD) Change
9.71%
1-Year Change
44.06%
3-Year Change
-99.86%
5-Year Change
-99.99%
All-Time (Max) Change
-100.00%

Contact Information

https://www.endrainc.com
734 335 0468
3600 Green Court, Ann Arbor, MI, 48105-1570

Company Facts

21 Employees
IPO DateJun 30, 2017
CountryUS
Actively Trading

Frequently Asked Questions